Resources

The latest in biomarkers research, from development and diagnostics to precision medicine

Biomarker Technologies

The Power of Real-World Data Analytics in Biomarker Discovery: A Game-Changer in Medical Research

Biomarker discovery in medical research traditionally relied on controlled trials. Now, Real-World Data Analytics offers a transformative approach, analyzing real-world patient data to identify new biomarkers and improve patient care.
Biomarker Technologies

Post-Event Proceedings – Biomarkers 2023

Concise and insightful summaries of presentations delivered by prominent thought leaders at Biomarkers 2023.
Biomarker Technologies

APIS Assay Technologies

Biomarker Technologies

Biomarker Strategies for Monitoring the Tumour Microenvironment

Here, we discuss the development and application of multiplex immunofluorescence-based biomarker strategies to study the tumour microenvironment in lymphoma patients, exploring how these approaches can help to identify immune cell interactions.
Biomarker Technologies

Interview with Simon Gao, Clinical Imaging Scientist at Genentech

Simon Gao of Genentech discusses his background in clinical imaging and the impact that AI-based approaches may have on biomarker discovery.
Biomarker Technologies

Blood Markers of Brain Health: The Simoa® Platform—Measuring CNS biomarkers in serum and plasma with ultrasensitivity

With a sensitivity many times greater than traditional ELISA methods, the Simoa® platform can measure brain biomarkers in blood, offering you another dimension of data from a readily available, non-invasive source.
Biomarker Technologies

Lung Cancer Patient Response to Immunotherapy Could be Predicted Through AI-Calculated Biomarker 

Breakthroughs in the use of AI for biomarker prediction and validation of efficacy could shape future treatments for immunotherapies. In this case study, we look at its applications in validating lung cancer patient responses to treatment.
Biomarker Technologies

Gyrolab - Bioaffy-4000 CD

Biomarker Technologies

Optimer - Drug Conjugates

Biomarker Technologies

Breath Biopsy Omni For Comprehensive & Reliable Detection Of VOC Biomarkers In Breath

On-Demand Webinar featuring Dr Elizabeth Crone, Business Development Manager at Owlstone & Dr Hsuan (Tina) Chou, Biomarker Scientist at Owlstone
Biomarker Technologies

Are Neuroimmune Proteins the Key to Neurodegenerative Disease Diagnosis?

Unique neuroinflammatory signatures and pathways present in tauopathies could provide greater insight into distinct mechanisms of disease.
Biomarker Technologies

Biomarker Testing Consolidation and Implementation Using Multiplex Immunofluorescence

Multiplex immunofluorescence is gaining prevalence in oncology diagnostics; what makes it so effective, and how is it being brought into the clinic?
Biomarker Technologies

RNA Sequencing - MiRXES

Biomarker Technologies

GOAL: A Collaborative Approach to Next Generation Sequencing in Oncology and Beyond

The Genomics Organisation for Academic Laboratories – known also to the world as GOAL – is a collaborative project set up by a group of academic centres across the United States to facilitate affordable next generation sequencing. The long-term target is to expand patient access to personalised genomic testing, as well as future biomarker discovery.
Biomarker Technologies

Enabling Precision Oncology with Tumour Profiling Solutions

Erin Newburn, Senior Director, Field Applications Scientist at Personalis, Inc. showcases the Personalis NeXT Platform ®, a tumour profiling solution for both tissue and liquid biopsies at Biomarkers UK 2022.
Biomarker Technologies

Unlocking the Potential of Spatial Multi-Omics and Cytometry

Senior representatives from Ultivue, Genentech, and GSK discuss the current trends and opportunities in enabling the future of multi-omics-based analysis.
Biomarker Technologies

Spatial Biomarkers & Multiplexed Immunofluorescence in Immuno-Oncology

Yu Liang, Director of Clinical Biomarkers at Compugen, leads a discussion on ‘Spatial Biomarkers & Multiplexed Immunofluorescence in Immuno-Oncology.’
Biomarker Technologies

CLARA: Total mRNA Report

Biomarker Technologies

Indivumed: Liquid Biopsy

Biomarker Technologies

TruCulture Catalogue

Biomarker Technologies

xMAP INTELLIFLEX Systems

Biomarker Technologies

Implementing Flow Cytometry Assays In Biomarker Research

Oxford Global’s Discussion Groups provide a focused networking opportunity for a select group of like-minded experts on a monthly basis. Our first Biomarkers Discussion Group addressing ‘Implementing Flow Cytometry Assays In Biomarker Research’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biomarkers